Top Industry Leaders in the Cardiac Valve Market
Edwards Lifesciences' TAVR Melodyโข 34 Valve: In October 2023, Edwards Lifesciences received FDA approval for its TAVR Melodyโข 34 valve, the first transcatheter aortic valve replacement (TAVR) device specifically designed for patients with smaller aortic annuli. This expands treatment options for a previously underserved patient population.
Abbott's Porticoโข Transcatheter Mitral Valve System: In November 2023, Abbott announced the initiation of a pivotal US clinical trial for its Porticoโข Transcatheter Mitral Valve System, a less invasive treatment option for mitral valve regurgitation. Positive results could significantly impact the market landscape.
Medtronic's Harmonyโข Transcatheter Valve System: Medtronic is pursuing FDA approval for its Harmonyโข Transcatheter Valve System, a next-generation TAVR device featuring a repositionable and retrievable design for enhanced procedural control and safety.
List of Cardiac Valve Key Companies in the Market
- Medtronic
- Edwards Lifesciences Corporation
- Boston Scientific Corporation
- LivaNova PLC
- Abbott
- CryoLife, Inc
- On-X Life Technologies, Inc.
- Colibri Heart Valve
- JenaValve Technology, Inc.
- TTK HealthCare